Abstract
Methylmalonic acidemia (MMA) is an inborn error of metabolism caused by either deficiency of the enzyme methylmalonyl-CoA mutase or a defect in adenosyl-cobalamin synthesis. Chronic kidney disease is its common complication and, in combination with persistent acidosis, leads to hyperuricemia. Symptomatic hyperuricemia or gout, however, has not been reported in MMA. We herein report two pediatric cases of MMA caused by MMAB mutations (cblB defect) with renal tubular acidosis, chronic kidney disease, hyperuricemia, and gout. The clinical findings of gout in these cases included recurrent first metatarsophalangeal arthritis and/or tophi. The patients responded to treatment with colchicine and allopurinol.
| Original language | English |
|---|---|
| Pages (from-to) | 501-503 |
| Number of pages | 3 |
| Journal | Pediatrics International |
| Volume | 58 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Jun 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- chronic kidney disease
- gout
- hyperuricemia
- juvenile
- methylmalonic acidemia
Fingerprint
Dive into the research topics of 'Juvenile gout in methylmalonic acidemia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver